AR052743A1 - PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS - Google Patents

PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS

Info

Publication number
AR052743A1
AR052743A1 ARP060101408A ARP060101408A AR052743A1 AR 052743 A1 AR052743 A1 AR 052743A1 AR P060101408 A ARP060101408 A AR P060101408A AR P060101408 A ARP060101408 A AR P060101408A AR 052743 A1 AR052743 A1 AR 052743A1
Authority
AR
Argentina
Prior art keywords
canarypox virus
seq
transfer vector
plasmidic
virus
Prior art date
Application number
ARP060101408A
Other languages
Spanish (es)
Inventor
Gabriela Calamante
Grand Daniela Maria Conte
Elisa Cristina Carrillo
Original Assignee
Inst Nac De Tecnologia Agropec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nac De Tecnologia Agropec filed Critical Inst Nac De Tecnologia Agropec
Priority to ARP060101408A priority Critical patent/AR052743A1/en
Publication of AR052743A1 publication Critical patent/AR052743A1/en
Priority to PCT/BR2007/000087 priority patent/WO2007115385A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/40—Systems of functionally co-operating vectors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se provee un virus recombinante a partir del virus canarypox (CNPV), capaz de actuar in vivo como vector de expresion de genes foráneos insertados en regiones genomicas no esenciales para la replicacion viral, con mayor estabilidad genética, donde dichas reguins genomicas corresponden a al menos un gen seleccionado de CNPV018 (SEQ ID No. 1), CNPV048 (SEQ ID No. 2) y CNPV134 (SEQ ID No. 3), del genoma del virus canarypox. Se provee un vector plasmídico de transferencia, suceptible de recombinacion hoologa con un virus canarypox. Además se proveen vacunas y métodos de inmunizacion.A recombinant virus is provided from the canarypox virus (CNPV), capable of acting in vivo as an expression vector of foreign genes inserted in non-essential genomic regions for viral replication, with greater genetic stability, where said genomic reguins correspond to at least a gene selected from CNPV018 (SEQ ID No. 1), CNPV048 (SEQ ID No. 2) and CNPV134 (SEQ ID No. 3), from the canarypox virus genome. A plasmid transfer vector, susceptible to hoologo recombination with a canarypox virus, is provided. In addition, vaccines and immunization methods are provided.

ARP060101408A 2006-04-10 2006-04-11 PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS AR052743A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP060101408A AR052743A1 (en) 2006-04-11 2006-04-11 PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS
PCT/BR2007/000087 WO2007115385A2 (en) 2006-04-10 2007-04-09 Transfer plasmidic vector and recombinant canarypox virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP060101408A AR052743A1 (en) 2006-04-11 2006-04-11 PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS

Publications (1)

Publication Number Publication Date
AR052743A1 true AR052743A1 (en) 2007-03-28

Family

ID=37908497

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101408A AR052743A1 (en) 2006-04-10 2006-04-11 PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS

Country Status (2)

Country Link
AR (1) AR052743A1 (en)
WO (1) WO2007115385A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103740758B (en) * 2013-12-18 2015-03-18 广东华南联合疫苗开发院有限公司 Recombinant baculovirus vector, virus like particle, preparation method and use
CN103710384A (en) * 2013-12-18 2014-04-09 广东华南联合疫苗开发院有限公司 Picornaviridae recombinant vector, virus like particle, and preparation method and use of virus like particle
CN113388587B (en) * 2021-07-06 2023-09-26 天康制药股份有限公司 Recombinant bovine nodavirus expressing bovine viral diarrhea E2 gene and application thereof
CN116656730B (en) * 2023-05-25 2024-03-19 军事科学院军事医学研究院军事兽医研究所 Recombinant canary pox virus expressing rabies virus G, M protein and construction method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE71643B1 (en) * 1990-11-20 1997-02-26 Virogenetics Corp A recombinant poxviral vaccine for canine distemper
FR2766091A1 (en) * 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION
DE10221411B4 (en) * 2002-05-14 2004-07-08 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Recombinant fowlpox virus

Also Published As

Publication number Publication date
WO2007115385A3 (en) 2008-01-10
WO2007115385A2 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
Grimm et al. Small but increasingly mighty: latest advances in AAV vector research, design, and evolution
US20230287401A1 (en) Rna guided compositions for preventing and treating hepatitis b virus infections
Geisler et al. MicroRNA-regulated viral vectors for gene therapy
ES2526191T3 (en) Method to produce infectious influenza B virus in cell culture
Quabius et al. Synthetic mRNAs for manipulating cellular phenotypes: an overview
ES2610781T3 (en) Strain independent pathogen amplification and vaccines for these
MX2010007336A (en) Protein expression systems.
WO2010127166A3 (en) Combination anti-hiv vectors, targeting vectors, and methods of use
NZ592082A (en) Promoters for recombinant viral expression
JP2010259446A5 (en)
EP3548614A1 (en) SYSTEMS AND METHODS FOR ONE-SHOT GUIDE RNA (ogRNA) TARGETING OF ENDOGENOUS AND SOURCE DNA
AU2016355468A1 (en) CMV vectors comprising microRNA recognition elements
WO2006069064A3 (en) Conserved hbv and hcv sequences useful for gene silencing
AR052743A1 (en) PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS
ATE494381T1 (en) IMPROVED EXPRESSION ELEMENTS
RS50977B (en) Replication-deficient rna viruses as vaccines
CN111511914A (en) Nucleic acid molecules that reduce PAPD5 and PAPD7mRNA for the treatment of hepatitis B infection
MX2021004455A (en) Compositions and methods for delivering transgenes.
CN103627718A (en) S1 and N double-antigen protein recombinant plasmid capable of expressing IBV (Infectious Bronchitis Virus) and construction method and application thereof
CN107828788B (en) Application of lncRNA related to PRRSV infection and siRNA thereof in inhibiting virus replication
CN112760320B (en) Exogenous artificial miRNA for effectively inhibiting replication of porcine epidemic diarrhea virus and application thereof
CN102304580B (en) Method for screening pig disease resistant breeds, and application thereof
JP2009232836A5 (en)
CN105925613B (en) Promote the highly expressed Lentiviral of liver cell miR-199b and its construction method
WO2008108344A1 (en) Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell

Legal Events

Date Code Title Description
FG Grant, registration